Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Diarrhea × maltodextrin × Clear all

Phase

Phase NA 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Vaso-Occlusive Crises 1 Neoplasms 1 Diarrhea 1 Anemia, Sickle Cell 1

Interventions

Octreotide 3 maltodextrin 1 lanreotide 1 Sulfasalazine 1 Radiation 1 Loperamide 1 Levofloxacin 1 Irinotecan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02819960 2022-12-14

Prevention of Irinotecan Induced Diarrhea by Probiotics

S&D Pharma SK s.r.o.

Phase 3 Completed

Diarrhea, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡